Level Biotechnology (3118) — Financial Flexibility Index
Level Biotechnology (3118) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of NT$16.26 Million (operating CF NT$11.81 Million minus capex NT$4.44 Million) represents 0% of total liabilities (NT$237.03 Million). Also explore 3118 net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Level Biotechnology Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Level Biotechnology across 8 annual periods. Check Level Biotechnology (3118) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Level Biotechnology (2017–2024)
Year-by-year free cash flow to debt coverage for Level Biotechnology. For the full company profile including market capitalisation, see market cap of Level Biotechnology.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.08x | NT$287.77 Million | NT$64.10 Million | NT$267.19 Million | ▲ +277.8% |
| 2023 | 0.29x | NT$77.88 Million | NT$70.21 Million | NT$273.20 Million | ▲ +7.2% |
| 2022 | 0.27x | NT$71.81 Million | NT$65.07 Million | NT$270.13 Million | ▼ -60.9% |
| 2021 | 0.68x | NT$165.10 Million | NT$155.95 Million | NT$242.78 Million | ▲ +93.1% |
| 2020 | 0.35x | NT$85.77 Million | NT$83.23 Million | NT$243.56 Million | ▼ -25.3% |
| 2019 | 0.47x | NT$111.45 Million | NT$109.02 Million | NT$236.43 Million | ▲ +192.3% |
| 2018 | 0.16x | NT$29.29 Million | NT$26.77 Million | NT$181.60 Million | ▼ -58.8% |
| 2017 | 0.39x | NT$82.12 Million | NT$71.29 Million | NT$210.03 Million | — |